Finance

Lists
Why is SCTX down 3.44%?
Dive Deeper
SCTX:NASDAQ
Scribe Therapeutics Inc
$19.39
-3.44%
(-0.69) 1D
$19.39
0.00% (0.00)
After hours
Closed: Oct 19, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SCTX...
Open
$20.09
High
$20.92
Low
$18.27
Mkt. cap
367.09M
Avg. vol.
476.44K
Volume
259.37K
52-wk high
$39.60
52-wk low
$13.50
EPS
-$1.84
No. of employees
82
Open
$20.09
High
$20.92
Low
$18.27
Mkt. cap
367.09M
Avg. vol.
476.44K
Volume
259.37K
52-wk high
$39.60
52-wk low
$13.50
EPS
-$1.84
No. of employees
82
News stories
From web sources and news partners
About Scribe Therapeutics Inc
CEO-
Employees82
Founded2017
Headquarters-
SectorBiotechnology
Websitescribetx.com
Analyst ratings
Based on 4 analysts giving stock ratings to SCTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for SCTX in the last 3 months.
Highest
Current $19.39
$60.00 (+209.44%)
Average
$51.75 (+166.89%)
Lowest
$37.00 (+90.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
$60.00
+209.4%
09/03/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
$60.00
+209.4%
08/31/2026
David Risinger
Leerink Partners
Buy
Initiated
$37.00
+90.8%
08/18/2026
Debjit Chattopadhyay
Guggenheim
Buy
Initiated
$50.00
+157.9%
08/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
17.12M
4.90M
2.23M
1.92M
Cost of goods sold
15.99M
13.88M
11.30M
8.82M
Cost of revenue
15.99M
13.88M
11.30M
8.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.69M
2.64M
3.36M
2.49M
Operating expense
6.69M
2.64M
3.36M
2.49M
Total operating expenses
22.68M
16.52M
14.66M
11.31M
Operating income
-5.56M
-11.63M
-12.43M
-9.40M
Other non operating income
-
-
-
-
EBT including unusual items
-3.74M
-10.62M
-17.12M
-6.26M
EBT excluding unusual items
-5.09M
-11.34M
-12.51M
-9.29M
Income tax expense
-315.00K
-712.00K
228.00K
212.00K
Effective tax rate
8.42%
6.71%
-1.33%
-3.38%
Other operating expenses
-
-
-
-
Net income
-3.42M
-9.90M
-17.35M
-6.48M
Net profit margin
-20.00%
-202.18%
-776.85%
-337.70%
Earnings per share
-
-
-
-2.62
Interest and investment income
1.06M
880.00K
515.00K
383.00K
Interest expense
-598.00K
-598.00K
-598.00K
-276.00K
Net interest expenses
465.00K
282.00K
-83.00K
107.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.81M
-10.91M
-11.79M
-8.75M
Gain or loss from assets sale
-
5.00K
3.00K
1.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps